Abstract
Micelle-forming block copolymer-drug conjugates offer a new vehicle design for drug delivery that may be useful for the targeting of tumors. We have investigated the biodistribution of poly (ethylene oxide-aspartate) block copolymer-adriamycin conjugates (PEO-PAsp(ADR)) in murine colon adenocarcinoma 26 (C-26) tumor-bearing mice after intravenous (i.v.) injection. For PEO-PAsp(ADR) conjugates, long circulation times in blood and a concomitant reduced uptake in the major organs of the reticuloendothelial system (RES) (i.e., liver and spleen) were demonstrated. This was consistent with the in vivo persistence of a micellar core/shell structure in which the conjugate is known to adopt. In this micellar structure, the PAsp(ADR) blocks are surrounded by a palisade of PEO chains. An enhanced accumulation in tumors of the micelle-forming PEO-PAsp(ADR) conjugates after 24 h (ca. 10% dose per g tumor), relative to free ADR (ca. 0.90% dose per g tumor), was demonstrated. Further, peak levels ofPEO-PAsp(ADR) conjugate in the heart (ca. 1.7% dose per g organ) were lower than for free ADR (ca. 6.2% dose per g organ). The results indicate that ADR associated with the micelleforming PEO-PAsp(ADR) conjugates is more efficaciously delivered to tumor sites than free ADR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
